PG2 based on Chinese medicine: Phase I testing

Pharmagenesis Inc., Palo Alto, Calif. Product: PG2 based on Chinese medicine Indication: Alleviate neutropenia, thrombocytopenia, and anemia from chemotherapy in cancer Status: Began Phase I testing i...